Acclaro Medical
Latest round
- Series B
Last raised
- May 2025
Total raised
- $23M
Investors
- 2
About Acclaro Medical
Founded in 2018 and headquartered in Smithfield, US, Acclaro Medical focuses on advanced skin health solutions. Founded in 2018 and headquartered in Smithfield, US, Acclaro Medical focuses on advanced skin health solutions. Acclaro Medical offers a range of advanced skin rejuvenation technologies under the UltraClear Laser brand. This includes proprietary services utilizing the 3DMIRACL laser and 3DIntelliPulse technology, designed to treat skin conditions such as deep wrinkles, scars, and age spots. The treatments are non-invasive and cater to a diverse clientele, addressing the needs of individuals across various skin types. UltraClear Laser's products are marketed in North America, Europe, and select Asian markets, targeting aesthetic clinics and medical practices that seek to enhance patient experiences in cosmetic dermatology. The revenue model for Acclaro Medical is centered on B2B transactions, primarily involving the sale of its advanced laser systems and consumables to aesthetic and medical practices. Clients directly purchase the UltraClear platform, which includes options for training and ongoing support services. The flagship products, including the 3DMIRACL and 3DIntelliPulse lasers, are critical to their service offering. Pricing is based on equipment and service agreements, ensuring that practices can integrate UltraClear’s technology into their operations efficiently.00 mn to accelerate its expansion in the skin health sector. The company is developing new products aimed at enhancing its existing offerings, although specific release dates have yet to be announced. Additionally, Acclaro Medical is targeting further market expansion, with plans to enter additional international regions by the end of 2025, enhancing its presence in the cosmetic dermatology market.
Who invested in Acclaro Medical
2 investors across 1 round
See all investors in Acclaro Medical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
May 29, 2025
Amount
$23M
Investors
Questions about Acclaro Medical
Who invested in Acclaro Medical?
Acclaro Medical has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Acclaro Medical raised?
Acclaro Medical has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Acclaro Medical last raise money?
Acclaro Medical's most recent round on record is a Series B, in May 2025.
What does Acclaro Medical do?
Founded in 2018 and headquartered in Smithfield, US, Acclaro Medical focuses on advanced skin health solutions.
Where is Acclaro Medical headquartered?
Acclaro Medical is headquartered in Smithfield, US.
Which VCs invest in companies like Acclaro Medical?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Acclaro Medical's stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like Acclaro Medical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.